Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment.
Overview
N-acetylcysteine (NAC; acetylcysteine) is used as an antidote for acetaminophen/paracetamol poisoning and as a mucolytic in selected respiratory conditions. Mechanisms include supplying cysteine for glutathione synthesis and reducing disulfide bonds in mucoproteins. Evidence for unapproved ‘antioxidant’ uses is not equivalent to its life-saving antidotal efficacy [1,2].
Mechanisms
A portion of acetaminophen undergoes cytochrome P450-mediated oxidation to reactive N-acetyl-p-benzoquinone imine (NAPQI), normally neutralized by glutathione. Overdose overwhelms glutathione stores; NAC supplies cysteine for glutathione restoration and may improve additional mitochondrial/redox pathways. As a nebulized or topical mucolytic, NAC cleaves disulfide bridges in mucus glycoproteins, reducing viscosity. These are distinct mechanisms requiring distinct routes and product formulations [1].
Evidence-based overdose assessment
Paracetamol poisoning is a medical emergency that may produce delayed liver injury despite initially few symptoms. For a known-time single acute ingestion, clinicians use timed paracetamol levels and the revised Rumack–Matthew nomogram, with careful attention to timing, uncertain history, repeated supratherapeutic exposure, sustained-release ingestion and co-ingestions. A concentration drawn earlier than four hours cannot be used as a routine nomogram treatment decision. Poison-center consultation is valuable when timing or risk is uncertain [2].
Antidote administration and stopping criteria
NAC can be administered orally or intravenously in validated weight-based protocols. The 2023 US/Canada consensus statement recommends providing at least 300 mg/kg during the first 20–24 hours when treatment is indicated, with regimen choice adapted to patient and setting. Do not stop NAC solely because 20 or 21 hours have elapsed: reassess acetaminophen concentration, AST/ALT, INR and clinical status and continue until specified stopping criteria are met. High-risk ingestion or liver failure may need prolonged or intensified therapy and expert consultation [2].
Safety, interactions and special groups
IV NAC may cause non-IgE infusion reactions with flushing, rash, bronchospasm or hypotension, often manageable by pausing/slowing infusion and treating symptoms without permanently abandoning indicated antidotal therapy. Oral NAC commonly causes nausea and vomiting. Nebulized NAC can provoke bronchospasm in reactive airways; suction and airway monitoring may be needed in patients unable to clear liquefied mucus. Avoid confusing oral/IV antidote protocols with inhaled mucolytic dosing [1,2].
Clinical takeaways
The antidotal indication is backed by substantial clinical experience and national consensus recommendations. Other proposed uses—such as routine treatment of COPD exacerbations or broad prevention of oxidative disease—need indication-specific evidence and should not be portrayed as universal standard care [1,2].
References
- Brunton LL, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. McGraw Hill; 2023.
- Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open. 2023;6(8):e2327739. doi:10.1001/jamanetworkopen.2023.27739. Available from: https://doi.org/10.1001/jamanetworkopen.2023.27739
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.